Innovative pharmas spend 12% of sales into R&D

Published: 2016-11-30 15:54:03

Updated: 2016-11-30 15:54:03

It was observed innovative pharmaceutical companies spent 12% of their sales into R&D on average, and Celltrion and Hanmi Pharm were the ones which spend the most.

According to the Yakup Shinmoon’s(www.yakup.com) analysis result of 2016 3^rd quarter performance reports turned in by companies certified as innovative pharmaceutical company, their average R&D/sales ratio was 12.2%. (SK Chemicals w...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.